Coya Therapeutics (COYA) Return on Sales (2023 - 2025)
Coya Therapeutics (COYA) has disclosed Return on Sales for 3 consecutive years, with 3.05% as the latest value for Q4 2025.
- Quarterly Return on Sales fell 506519.0% to 3.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.47% through Dec 2025, up 23.0% year-over-year, with the annual reading at 2.67% for FY2025, 152.0% up from the prior year.
- Return on Sales hit 3.05% in Q4 2025 for Coya Therapeutics, up from 0.68% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 5068.23% in Q4 2024 to a low of 39.83% in Q1 2024.
- Historically, Return on Sales has averaged 551.5% across 3 years, with a median of 0.84% in 2024.
- Biggest five-year swings in Return on Sales: soared 506793bps in 2024 and later crashed -506519bps in 2025.
- Year by year, Return on Sales stood at 0.3% in 2023, then soared by 1675822bps to 5068.23% in 2024, then plummeted by -100bps to 3.05% in 2025.
- Business Quant data shows Return on Sales for COYA at 3.05% in Q4 2025, 0.68% in Q3 2025, and 37.25% in Q2 2025.